期刊文献+

散发性Alzheimer病患者脑源性神经营养因子基因C270T多态性的研究 被引量:1

Investigate on the polymorphism of brain-derived neurotrophic factor gene C270T in patients with sporadic Alzheimer's disease
下载PDF
导出
摘要 目的探讨中国汉族人群散发性Alzheimer病(SAD)患者脑源性神经营养因子(BDNF)基因C270T多态性与AD发病的关系。方法采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)技术,检测55例SAD患者和80名年龄、性别匹配的健康人(正常对照组)BDNF基因C270T多态性,比较两组基因型分布和等位基因频率。结果正常对照组BDNFC270T基因型及等位基因频率分布符合Hardy-Weinberg定律(χ2=0.167,P=0.682),SAD组基因型[C/C型52例(94.5%),C/T型3例(5.5%)]及等位基因频率(C97.27%,T2.73%)分布与正常对照组[C/C型74例(92.5%),C/T型6例(7.5%);C96.25%,T3.75%]比较差异无统计学意义。结论中国汉族人群BDNF基因C270T多态性与SAD的发病无明显关系。 Objective To investigate the association between the polymorphisms of brain-derived neurotrophic factor (BDNF) gene C270T and sporadic Alzheimer's disease (SAD) in Han Chinese. Methods The polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP) was used to detect BDNF gene C270T genotype and allele frequencies in 55 SAD patients and 80 age- and sex-matched healthy people( as normal control group). Results The frequencies distribution of BDNF gene C270T genotype and allele in the normal control group were suit to Hardy-Weinberg equilibrium (χ^2 = 0. 167, P = 0.682). The frequencies distribution of genotype and allele in the SAD group[ C/C:52(94.5% ), C/T:3(5.5% ) and C:97.27%, T:2.73% ] and normal control group[ C/C:74 (92.5%), C/T:6(7.5% ) and C :96.25%, T:3.75% ] were no statistical differences. Conclusion There is no association between the polymorphisms of BDNF gene C270T and SAD in Han Chinese.
出处 《临床神经病学杂志》 CAS 北大核心 2009年第2期90-92,共3页 Journal of Clinical Neurology
基金 广东省自然科学基金自由申请项目(05001277)
关键词 ALZHEIMER病 脑源性神经营养因子 基因多态性 Alzheimer's disease brain-derived neurotrophic factor gene polymorphism
  • 相关文献

参考文献9

  • 1Holsinger RM, Sehnarr J, Henry P, et al. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease [J]. Brain Res Mol Brain Res,2000,76:347.
  • 2Hashimoto Y, Abiru Y, Nishio C, et al. Synergistic effects of brain- derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergie neurons from postnatal 2-week-old rats[J]. Brain Res Dev Brain Res,1999, 115: 25.
  • 3Mizuno M, Yamada K, Olariu A, et al. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats [ J ]. J Neurosci, 2000, 20: 7116.
  • 4Kunugi H, Ueki A, Otsuka M, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with lateonset Alzheimer's disease[ J ]. Mol Psychiatry,2001,6: 83.
  • 5Riemenschneider M, Schwarz S, Wagenpfeil S, et al. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele[J]. Mol Psychiatry,2002, 7: 782.
  • 6Matsushita S, Arai H, Matsui T, et al. Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease [ J ]. J Neural Transm,2005, 112: 703.
  • 7Nishimura AL, Oliveira JR, Mitne-Neto M, et al. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients[ J]. J Mol Neurosci,2004, 22 : 257.
  • 8丁新生.重视Alzheimer病的诊治[J].临床神经病学杂志,2005,18(4):241-243. 被引量:17
  • 9Tsai S J, Hong C J, Liu HC, et al. The brain-derived neurotrophie factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population[ J]. Dement Geriatr Cogn Disord,2006, 21 : 139.

二级参考文献18

  • 1Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials[J]. Arch Neurol, 2004,61:59.
  • 2Borroni B,Rozzini L, Broglio L, et al.Platelet amyloid precursor protein abnormalities in mild congnitive impairment predict conversion to dementia of Alzheimer type[J]. Arch Neurol,2003,60:1740.
  • 3Emre M,Hanagasi HA. Evidence-based pharmacological treatment of dementia[J]. Eur J Neuro,2000, 7: 247.
  • 4Mackenzis IR,Moons DG. Nonsteroid anti-in-flammatory drug use and Alzheimer-type pathology in aging[J].Neurology, 1998,50: 986.
  • 5Tierney MC, Fisher RH, Lewis AJ,et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease : A clinic-pathologic study of 57 cases[J]. Neurology, 1988, 38:359.
  • 6Blacker D, A lbertM S, Bassett SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimar's disease[J] . Arch Neuro, 1994, 51: 1198.
  • 7Morris JC, Heyman A, Mohs RC, et al. The consortium to a registry for Alzheimer's disease part Ⅰ. Clinical and neuropsychological assessment of Alzheimer's disease[J]. Neurology, 1989, 39:1159.
  • 8Palmer K, Bckman L, Winblad B, et al. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study[J]. BMJ,2003,326:245.
  • 9Chui H. Reaching a diagnosis of a dementia subtype. In: Qizilbash N, ed. Evidence-based dementia practice[M]. Oxford, England: Blackwell Science, 2002.106.
  • 10Boxer AL, Rankin KP, Miller BL, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia[J]. Arch Neurol,2003, 60:959.

共引文献16

同被引文献14

  • 1李英平,郭瑞芳,李育臣,李红艳.局灶性脑缺血大鼠海马区不同部位BDNF的表达及其意义[J].中国老年学杂志,2004,24(12):1180-1182. 被引量:17
  • 2Figurov A, Pozzo-Miller LD, Olafsson P, et al. Regulation of synaptic responses to high frequency stimulation and LTP by neurotrophins in the hippocampus[J]. Nature, 1996, 381 : 706.
  • 3Rockwood K, Howard K,MacKnight C,et al. Spectrum of disease in vascular cognitive impairment[J]. Neuroepidemiology, 1999, 18: 248.
  • 4Chie Y,Kenji K, Toshio Y, et al. Serum BDNF, TNF-α and IL-1β levels in dementia patients[ J ]. Eur Arch Psychiatry Clin Neurosci, 2006, 256 : 402.
  • 5Miyake K, Yamamoto W, Tadokoro M, et al. Alterations in hippocampal GAP-43, BDNF, and LI following sustained cerebral ischemia[J]. Brain Res, 2002, 935: 24.
  • 6Pan W, Banks WA, Fasold MB, et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier[ J]. Neuropharmacology, 1998, 37: 1553.
  • 7Lindvall O, Ernfors P, Bengzon T, et al. Differential regulation of mRNAs for nerve growth factor, brain-derlved neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma[J]. Proc Natl Acad Sci USA, 1992, 89: 648.
  • 8Arai S, Kinouchi H, Akabane A, et al. Induction of brain-derived neurotrophic factor(BDNF) and the receptor trkB mRNA following middle cerebral artery occlusion in rat [ J]. Neurosic Lett, 1996, 211: 57.
  • 9Ferre I, Krupinski J, Goutan E, et al. Brain-derived neurotrophic factor reduces cortical cell death by ischemic after middle cerebral artery, occlusion in the rat [J]. Acta Neuropathol (Berl), 2001, 101 : 229.
  • 10Kinoshita Y, Ueyama T, Senba E, et al. Expression of c-fos, heat shock protein70, Neurotrophins, and cycloxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their mofication by magnesium sulfate[ J] . Neurotrauma, 2002, 18 : 435.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部